KM
Kevin J McNamara (president and CEO) filed 9 Form 4 reports in the trailing twelve months (0 purchases, 9 sales), most often in Chemed Corporation (CHE). The largest single filing was $1.1M of CHE (2,000 sh × $541.16, as filed), executed Aug 21. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
9
0 buys · 9 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.5M
shares × price, as filed
Last traded
Nov 3
Filed Nov 5
Median ADV $102.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $13.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
9 filings
Sector per market data · by filing · past 12 months
Most traded names
CHE
Chemed Corporation
CHE · 0 buys · 15 sells
15 filings
Recent filings
CHESALE
Chemed Corporation
View filing →
$875K2,000 sh × $437.55
Exec Nov 24 2025
Filed Nov 25 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $1.4M
3,000 sh × $461.28
Exec Sep 26 2025
Filed Sep 29 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $857K
2,000 sh × $428.55
Exec Aug 5 2025
Filed Aug 5 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $865K
1,500 sh × $576.45
Exec May 5 2025
Filed May 6 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $615K
1,000 sh × $615.33
Exec Mar 31 2025
Filed Apr 1 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $1.2M
2,000 sh × $593.67
Exec Mar 6 2025
Filed Mar 7 2025 · 5:30 PM ET CHESALE Chemed Corporation View filing → $1.1M
2,000 sh × $572.77
Exec Nov 25 2024
Filed Nov 26 2024 · 5:30 PM ET